Kyntra Bio Appoints Director Singer
Kyntra Bio appointed Andrew Singer to its board as independent director and Audit Committee member; simultaneously, Maykin Ho stepped down following eight years of service. This leadership change aligns with the company's expansion in rare disease and oncology.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed